Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: A follow-up of a randomised controlled trial

BMJ Open

Volumn 5, Issue 3, 2015, Pages

  Collins, Carmel T ^a,b,c,d   Gibson, Robert A ^a,b,d   Anderson, Peter J ^e,f   McPhee, Andrew J ^b,c,g   Sullivan, Thomas R ^d   Gould, Jacqueline F ^a,d   Ryan, Philip ^d   Doyle, Lex W ^e,f,h   Davis, Peter G ^e,h   McMichael, Judy E ^i,j   French, Noel P ^i,j   Colditz, Paul B ^k   Simmer, Karen ^i,j   Morris, Scott A ^l   Makrides, Maria ^a,b,c,d  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^h ROYAL WOMEN'S HOSPITAL   (Australia)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^k UNIVERSITY OF QUEENSLAND   (Australia)

^l FLINDERS UNIVERSITY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID;

ARTICLE; ATTENTION; AUSTRALIA; BIRTH WEIGHT; BRAIN DEVELOPMENT; CHILD BEHAVIOR; CHILD NUTRITION; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE; INTELLIGENCE QUOTIENT; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTICENTER STUDY; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; TERTIARY CARE CENTER; WECHSLER INTELLIGENCE SCALE; CHILD; CHILD DEVELOPMENT; CLINICAL TRIAL; DIETARY SUPPLEMENT; DRUG EFFECTS; INFANT; PREMATURE BIRTH; PSYCHOLOGY; SEX DIFFERENCE;

CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTELLIGENCE; MALE; PREMATURE BIRTH; SEX FACTORS; WECHSLER SCALES;

EID: 84926452447     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-007314     Document Type: Article

References (31)

1. Kerr-Wilson CO, Mackay DF, Smith GC, et al. Meta-analysis of the association between preterm delivery and intelligence. J Public Health (Oxford) 2012;34:209-16.
2. Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr 2007;137:855-9.
3. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992;120:S129-38.
4. Lapillonne A, Groh-Wargo S, Gonzalez CH, et al. Lipid needs of preterm infants: updated recommendations. J Pediatr 2013;162:S37-47.
5. Henriksen C, Haugholt K, Lindgren M, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008;121:1137-45.
6. Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009;301:175-82.
7. Smithers LG, Gibson RA, McPhee A, et al. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. Am J Clin Nutr 2008;88:1049-56.
8. Hack M, Taylor HG, Drotar D, et al. Poor predictive validity of the bayley scales of infant development for cognitive function of extremely low birth weight children at school age. Pediatrics 2005;116:333-41.
9. Roberts G, Anderson PJ, Doyle LW; Group tVICS. The stability of the diagnosis of developmental disability between ages 2 and 8 in a geographic cohort of very preterm children born in 1997. Arch Dis Child 2010;95:786-90.
10. Wilson-Ching M, Pascoe L, Doyle LW, et al . Effects of correcting for prematurity on cognitive test scores in childhood. J Paediatr Child Health 2014;50:182-8.
11. Manly T, Robertson IH, Anderson V, et al. TEA-Ch: The test of everyday attention for children. Bury St Edmunds, England: Thames Valley Test Company Ltd, 1999.
12. Wilson-Ching M, Molloy CS, Anderson VA, et al. Attention difficulties in a contemporary geographic cohort of adolescents born extremely preterm/extremely low birth weight. JINS 2013;19:1097-108.
13. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007;16:219-42.
14. Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, 1987.
15. Carnielli VP, Simonato M, Verlato G, et al. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns fed formula with long-chain polyunsaturated fatty acids. Am J Clin Nutr 2007;86:1323-30.
16. Smithers LG, Gibson RA, McPhee A, et al. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial. Prostaglandins Leukot Essent Fatty Acids 2008;79:141-6.
17. Clandinin MT, Van Aerde JE, Parrott A, et al. Assessment of the efficacious dose of arachidonic and docosahexaenoic acids in preterm infant formulas: fatty acid composition of erythrocyte membrane lipids. Pediatr Res 1997;42:819-25.
18. Makrides M. DHA supplementation during the perinatal period and neurodevelopment: Do some babies benefit more than others? Prostaglandins Leukot Essent Fatty Acids 2013;88:87-90.
19. Johnson S, Hollis C, Marlow N, et al. Screening for childhood mental health disorders using the Strengths and Difficulties Questionnaire: the validity of multi-informant reports. Dev Med Child Neurol 2014;56:453-9.
20. Sullivan JR, Riccio CA. Diagnostic group differences in parent and teacher ratings on the BRIEF and Conners' Scales. J Atten Disord 2007;11:398-406.
21. Westerberg AC, Schei R, Henriksen C, et al. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 2011;100:47-52.
22. Isaacs EB, Ross S, Kennedy K, et al. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011;128:e890-8.
23. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004;144:471-9.
24. Smithers LG, Collins CT, Simmonds LA, et al. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010;91:628-34.
25. Makrides M, Gould JF, Gawlik NR, et al. Four-year follow-up of children born to women in a randomized trial of prenatal DHA supplementation. JAMA 2014;311:1802-4.
26. Mulder H, Pitchford NJ, Hagger MS, et al. Development of executive function and attention in preterm children: a systematic review. Dev Neuropsychol 2009;34:393-421.
27. Wong HS, Edwards P. Nature or nurture: a systematic review of the effect of socio-economic status on the developmental and cognitive outcomes of children born preterm. Matern Child Health J 2013;17:1689-700.
28. Schneider LA, Burns NR, Giles LC, et al. Cognitive abilities in preterm and term-born adolescents. J Pediatr 2014;165:170-7.
29. Fawer CL, Besnier S, Forcada M, et al. Influence of perinatal, developmental and environmental factors on cognitive abilities of preterm children without major impairments at 5 years. Early Hum Dev 1995;43:151-64.
30. Schmidt B, Anderson PJ, Doyle LW, et al. Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012;307:275-82.
31. Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 1998;17:407-29.